Puma Biotechnology

is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of HER2+ breast cancer patients...
Read more
Puma Biotechnology Chairman & CEO: Alan H. Auerbach

Chairman & CEO

Alan H. Auerbach

CEO Approval Rating

90/100

2010

PublicIndependent CompanyNASDAQPBYI

28342836 NAICS listing
Annual Revenue
$230.5M
Employees
200
Funding
$395M

Puma Biotechnology Competitors

1Seagen
2Genentech
3Novartis
4Juno Therapeutics
5Kite Pharma
6NantKwest
7Celgene
8Chinabio
9Altor BioScience
10ImmunoGen
See 18+ competitors

Trending Companies